Woodstock Has Lifted Its Bristol (BMY) Holding; Wilhelmina International (WHLM) Has 1 Sentiment

December 10, 2017 - By Henry Gaston

Woodstock Corp increased Bristol (BMY) stake by 29.86% reported in 2017Q2 SEC filing. Woodstock Corp acquired 6,705 shares as Bristol (BMY)’s stock declined 1.04%. The Woodstock Corp holds 29,160 shares with $1.63 million value, up from 22,455 last quarter. Bristol now has $102.16B valuation. The stock increased 0.94% or $0.58 during the last trading session, reaching $62.42. About 5.31M shares traded. Bristol-Myers Squibb Company (NYSE:BMY) has declined 23.19% since December 10, 2016 and is downtrending. It has underperformed by 39.89% the S&P500.

Wilhelmina International, Inc. provides fashion model and talent management services. The company has market cap of $34.44 million. The firm engages in the representation and management of models, entertainers, artists, athletes, and other talent to various clients. It currently has negative earnings. It offers fashion modeling and talent product-endorsement services to clients, such as advertising agencies, branded consumer goods companies, fashion designers, magazine publications, retailers, department stores, product catalogs, and Internet sites; and talent management services.

Since January 1, 0001, it had 1 insider buy, and 0 sales for $324,000 activity.

Wynnefield Capital Inc holds 0.74% of its portfolio in Wilhelmina International, Inc. for 305,998 shares. Blackrock Inc. owns 303 shares or 0% of their US portfolio. Moreover, Deutsche Bank Ag has 0% invested in the company for 1,379 shares. The Texas-based Financial Management Professionals Inc. has invested 0% in the stock. Morgan Stanley, a New York-based fund reported 15 shares.

It closed at $6.4 lastly. It is down 3.26% since December 10, 2016 and is uptrending. It has underperformed by 13.44% the S&P500.

Among 19 analysts covering Bristol-Myers Squibb Company (NYSE:BMY), 6 have Buy rating, 3 Sell and 10 Hold. Therefore 32% are positive. Bristol-Myers Squibb Company has $80 highest and $45 lowest target. $62.53’s average target is 0.18% above currents $62.42 stock price. Bristol-Myers Squibb Company had 69 analyst reports since July 28, 2015 according to SRatingsIntel. The rating was initiated by Robert W. Baird with “Outperform” on Wednesday, April 26. The firm has “Equal-Weight” rating given on Friday, September 9 by Barclays Capital. The stock of Bristol-Myers Squibb Company (NYSE:BMY) has “Buy” rating given on Wednesday, December 2 by Guggenheim. The firm earned “Underperform” rating on Friday, July 28 by BMO Capital Markets. The firm earned “Buy” rating on Thursday, July 27 by Leerink Swann. As per Monday, June 5, the company rating was maintained by BMO Capital Markets. The rating was maintained by Leerink Swann with “Outperform” on Monday, October 23. The firm has “Buy” rating given on Wednesday, October 18 by Citigroup. Hilliard Lyons downgraded the stock to “Hold” rating in Tuesday, September 12 report. On Monday, July 10 the stock rating was maintained by Cowen & Co with “Hold”.